ヤマウチ アキラ
Akira Yamauchi
山内 明 所属 川崎医科大学 医学部 基礎医学 生化学 職種 教授 |
|
言語種別 | 英語 |
発表タイトル | Discovery of Pyrazole-based Anti-cancer Compounds via Cell-based Drug Discovery |
会議名 | The 82nd Annual Meeting of Japan Cancer Association |
主催者 | Japan Cancer Association |
学会区分 | 全国規模の学会 |
発表形式 | ポスター掲示 |
講演区分 | 一般 |
発表者・共同発表者 | Yamauchi A, Okamoto S, Choshi T, Katase N, Tomonobu N, Kinoshita R, Sakaguchi M, Yamamura M. |
発表年月日 | 2023/09/23 |
国名 | 日本 |
開催地 (都市, 国名) |
横浜 |
開催期間 | 2023/09/21~2023/09/23 |
概要 | The development of new drugs for cancer therapy is a crucial topic for improving the lives of cancer patients. Wepreviously discovered a new compound 14-100 which showed an inhibition of pancreatic cancer cell dynamics despiteminimal cytotoxicity, using a Cell-based Drug Discovery approach. This compound inhibited the growth of pancreaticcancer as well as metastasis
in vivo using a mouse orthotopic xenograft model. Compound 14-100 is a pyrazole-basedcompound. Recently, we synthesized analogues of Compound 14-100 and evaluated the eff ect on pancreatic cancer celldynamics. We found that at least 18 compounds inhibited cell dynamics (Biomedicine & Pharmacotherapy 155 (2022)113733). Compound 14-100 and its analogues, discovered through a Cell-based Drug Discovery approach, have shownpromising activity against pancreatic cancer, and may represent a new class of drug candidates for this disease. |
researchmap用URL | https://www.c-linkage.co.jp/jca2023/index.html |